Skip to main content

Table 2 Study endpoints before delivery, at early postpartum period and 6 weeks postpartum

From: Relationship between patient ethnicity and prevalence of anemia during pregnancy and the puerperium period and compliance with healthcare recommendations - implications for targeted health policy

Group

N

Jews

N

Arabs

p value

Before delivery

 Hb

805

12.0 (1.2) [12.0,11.2–12.8]

723

11.9 (1.3) [11.9,11.0–12.7]

0.07

 HCT

805

35.1 (3.3) [35.2,33.2–37.3]

723

34.8 (3.5) [34.8,32.5–37.1]

0.03

 Hb < 10.5 g/dL

805

88 (11%)

723

98 (14%)

0.11

 Hb < 10 g/dL

805

49 (6%)

723

56 (8%)

0.2

 Hb ≤ 9.5 g/dL

805

26 (3%)

723

31 (4%)

0.28

ARS score ad

628

1.7 (1.8) [1.2,0.4–2.6]

570

2.6 (2.2)

[2.4,0.8–4]

<.0001

Early postpartum (during maternity department admission)

 Hb < 10 g/dLb

216

121 (56%)

197

115 (58%)

0.63

 Hb < 9.5 g/dL b

216

101 (47%)

197

102 (52%)

0.31

 Iron supplementation during pregnancy

572

518 (90%)

493

454 (92%)

0.38

 Treatment with IV iron sucrose for postpartum anemia

805

89 (11%)

723

106 (15%)

0.04

 Breastfeeding during admission at maternity department

610

533 (87%)

561

539 (96%)

<.0001

SF-36 itemsc

 SF-36 Physical Functioningd

602

73.3 (26.5) [80,55–95]

555

70.5 (24.4)

[75,55–90]

0.003

 SF-36 Role limitations due to physical health

595

32.9 (39.7)

[25,0–75]

543

37.5 (41.8)

[25,0–75]

0.1

 SF-36 Pain

585

53.5 (24.0) [55.0,32.5–67.5]

543

51.7 (24.7)

[45.0,35.0–67.5]

0.31

 SF-36 General Healthd

611

75.6 (14.0) [79.2,66.7–87.5]

569

66.3 (15.1) [66.7,58.3–75.0]

<.0001

 SF-36 Energy/fatigue

580

48.6 (18.1) [50,35–60]

529

47.4 (21.5)

[50,30–60]

0.34

 SF-36 Social functioningd

591

78.1 (19.7) [80.0,65.0–100]

541

70.6 (24.1) [77.5,55.0–90.0]

<.0001

 SF-36 Role limitations due tod emotional problems

585

67.2 (43.0) [100,33.3–100]

539

53.7 (45.4) [66.7,0–100]

<.0001

 SF-36 Emotional well-beingd

580

69.9 (10.6) [72,64–76]

530

61.3 (15.2)

[64,52–72]

<.0001

 ARS score after deliveryad

625

1.9 (2.0)

[1.4,0.6–2.8]

570

2.3 (2.2)

[1.8,0.6–3.4]

0.006

 Fatigue severity scale scoresa

570

32.8 (12.4) [33,23–42]

521

33.1 (14.1)

[33,21–44]

0.12

6 weeks Postpartum

 Breastfeeding ≥30 days

744

474 (64%)

647

539 (83%)

<.0001

 Iron supplementation during postpartum period

743

532 (72%)

647

537 (83%)

<.0001

 ARS scoread

745

0.5 (1.1) [0,0–0.4]

646

0.9 (1.4) [0,0–1.2]

<.0001

 Functional capacityd

744

9.2 (1.5)

[9, 10]

646

8.9 (1.8)

[8–10]

0.007

 Performed CBC

805

265 (33%)

723

242 (34%)

0.82

 Hb (g/dL)

265

12.7 (0.9) [12.7,12.1–13.3]

242

12.4 (1.0) [12.4,11.7–13.1]

<.0001

 Hb < 12 (g/dL)

265

55 (21%)

242

68 (28%)

0.054

 Hb < 11 (g/dL) d

265

8 (3%)

242

23 (10%)

0.002

  1. Values are presented as mean (SD) [median, IQR] or number (percent)
  2. a Anemia-related symptoms score was comprised of 5 questions regarding symptoms that are related to anemia (fatigue, dizziness, palpitations and shortness of breath), ranked on a scale of 0 (best) to 10 (worst); fatigue severity scale score was scored so that a high score defines a less favorable health state
  3. b Only women that performed CBC postpartum were included
  4. c The SF-36 items were scored such that a high score indicated a more favorable health state
  5. d After adjusting to group of original study, beta thalassemia minor, place of residence, socio-economic index value (below the median value versus at least the median value), only SF-36 Physical Functioning remained statistically significant (p = 0.03). The variable Hb < 11 g/dL was adjusted using multivariate logistic regression. The rest of the variables were adjusted using multivariate ANOVA
  6. ARS anemia-related symptoms; CBC complete blood count, Hb hemoglobin; HCT hematocrit
Back to article page

Israel Journal of Health Policy Research

ISSN: 2045-4015